Gilead Sciences, Inc.
Biopharmaceutical company known for HIV and Hepatitis C treatments. Strong cash flows support dividend program.
The Gilead Sciences, Inc. GILD dividend offers investors a current yield of 2.40% with 9 consecutive years of dividend payments, making it a compelling choice for income-focused portfolios.
Gilead Sciences, Inc. GILD Dividend Metrics
10-Year Dividend History
Annual Dividend per Share ($)
Investment Highlights
Proven Dividend Track Record
The Gilead Sciences, Inc. GILD dividend has been paid for 9 consecutive years, demonstrating consistent commitment to shareholder returns.
Attractive Dividend Yield
With a current dividend yield of 2.40%, Gilead Sciences, Inc. offers a balanced approach to dividend income and potential capital appreciation.
Dividend Sustainability
The payout ratio of 805% suggests a high commitment to current dividends, though it's important to monitor coverage going forward.
Investment Disclaimer
This information is provided for educational purposes only and does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Gilead Sciences, Inc. stock information, dividend metrics, and analysis are provided as-is without any warranty. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past dividend performance does not guarantee future results.